Skip to main content
An official website of the United States government

autologous tumor infiltrating lymphocytes GT101

A preparation of autologous tumor infiltrating lymphocytes (TILs) derived from each patient's resected tumor and expanded ex vivo, with potential immunomodulating and antineoplastic activities. Upon administration back into the patient, the autologous TILs GT101 specifically recognize and kill the patient's tumor cells.
Synonym:autologous TILs GT101
Code name:GT 101
GT-101
GT101
Search NCI's Drug Dictionary